05.02.2013 Views

Role of Intestinal Microbiota in Ulcerative Colitis

Role of Intestinal Microbiota in Ulcerative Colitis

Role of Intestinal Microbiota in Ulcerative Colitis

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Introduction<br />

Methodology part<br />

The aim <strong>of</strong> this study was to exam<strong>in</strong>e the ability <strong>of</strong> fecal microbiota derived from UC patients <strong>in</strong><br />

either remission or relapse, and healthy subjects to colonize an artificial mucus layer us<strong>in</strong>g a<br />

dynamic <strong>in</strong> vitro gut model.<br />

Flow diagram<br />

Paper 2<br />

The author, Louise K. Vigsnæs, participated <strong>in</strong> the design <strong>of</strong> the study, conducted the experiments,<br />

performed the data analyzes and drafted the manuscript.<br />

The manuscript is still <strong>in</strong> a prelim<strong>in</strong>ary state. The follow<strong>in</strong>g analyzes and data treatments will be<br />

added <strong>in</strong> the f<strong>in</strong>al version:<br />

• Growth curves for sixteen different bacterial taxa (see flow diagram): Samples were taken<br />

out at 0, 18, 26 and 42 hours from the lumen. Louise K. Vigsnæs is conduct<strong>in</strong>g these<br />

analyzes.<br />

• SCFA analysis for acetate, butyrate and propionate: Samples were taken out at 0, 1.5, 3, 5,<br />

18, 20, 22, 23.5, 25, and 42 hours. Louise K. Vigsnæs and Pieter Van den Abbeele are<br />

conduct<strong>in</strong>g these analyzes.<br />

• Mass spectrometry (MS) on samples from the lumen and mucus (42 hours). Karol<strong>in</strong>a Sulek<br />

is conduct<strong>in</strong>g the MS.<br />

70

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!